Balancing the safeguarding of privacy and data sharing: perceptions of genomic professionals on patient genomic data ownership in Australia

Abstract

There are inherent complexities and tensions in achieving a responsible balance between safeguarding patients’ privacy and sharing genomic data for advancing health and medical science. A growing body of literature suggests establishing patient genomic data ownership, enabled by blockchain technology, as one approach for managing these priorities. We conducted an online survey, applying a mixed methods approach to collect quantitative (using scale questions) and qualitative data (using open-ended questions). We explored the views of 117 genomic professionals (clinical geneticists, genetic counsellors, bioinformaticians, and researchers) towards patient data ownership in Australia. Data analysis revealed most professionals agreed that patients have rights to data ownership. However, there is a need for a clearer understanding of the nature and implications of data ownership in this context as genomic data often is subject to collective ownership (e.g., with family members and laboratories). This research finds that while the majority of genomic professionals acknowledge the desire for patient data ownership, bioinformaticians and researchers expressed more favourable views than clinical geneticists and genetic counsellors, suggesting that their views on this issue may be shaped by how closely they interact with patients as part of their professional duties. This research also confirms that stronger health system infrastructure is a prerequisite for enabling patient data ownership, which needs to be underpinned by appropriate digital infrastructure (e.g., central vs. decentralised data storage), patient identity ownership (e.g., limited vs. self-sovereign identity), and policy at both federal and state levels.

On the interconnected nature of risk and responsibility in the research and development of new and emerging technologies

“…Technology development is a process that involves multiple actors and institutions; decisions about risks, therefore, should arise from multi‐actor and multi‐institutional processes (Linkov et al., 2018; Renn, 2015). As these stakeholders might have different understandings of risks, a comprehensive risk analysis can only be achieved by engaging them in the process (Dalton‐Brown, 2016; Jones et al., 2014; Malakar, Lacey, Twine, McCrea, et al., 2023). Our study shows that a systematic approach to the identification and understanding of inclusion and reflection can be used to identify the full range and type of stakeholder roles in risk analysis.…”

Future-proofing genomic data and consent management: a comprehensive review of technology innovations

“…Similarly, values, beliefs, and protocols need to be respected when it comes to professional communities. For example, while clinicians support patients controlling their data, they are concerned about patients “owning” data [ 15 ], likely due to these creating difficulties around data provenance and the ramifications of using compromised data for clinical decisions. Thus, any developed framework must keep all involved stakeholders in mind and allocate resources for appropriate communication.…”

“…Clinicians typically rely on pathology providers to generate reports summarizing the genomic information to inform patient care. These reports are generated by multidisciplinary teams [ 15 ], but in the remaining article, we will refer to them as “pathology providers” for simplicity. While established clinical governance and security standards provide guidance for the management, storage, and analysis of genomic data for clinical care, it often conflicts with the need for broader access and sharing of this data for research [ 15 ].…”

“…These reports are generated by multidisciplinary teams [ 15 ], but in the remaining article, we will refer to them as “pathology providers” for simplicity. While established clinical governance and security standards provide guidance for the management, storage, and analysis of genomic data for clinical care, it often conflicts with the need for broader access and sharing of this data for research [ 15 ]. Platforms able to serve both clinical and research applications need to resolve the tension between the protective regulations in clinical settings and the exploratory objectives of research, as well as enable interoperability across the 2 domains.…”

Digital Literacy 5.0 to Enhance Multicultural Education

“…As bioinformatics plays a crucial role in areas like genomics and personalized medicine, education will need to address ethical considerations, data privacy, and responsible research practices (281).…”